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Abstract
Antibiotic resistance is increasing worldwide, and is considered a serious threat
to public health by e.g. the World Health Organization. Antibiotic resistance
genes are hypothesized to originate from harmless bacteria in and around
us, from where they are horizontally transfered into human pathogens. It is
therefore of great importance to explore human-associated and environmental
bacterial communities to identify novel antibiotic resistance genes before they
reach clinical settings. The three papers presented in this thesis aim to identify
novel antibiotic resistance genes in large genomic and metagenomic datasets. In
paper I, the aim was to identify novel genes of the clinically important subclass
B1 metallo-β-lactamases. By analyzing whole bacterial genomes as well as
metagenomes from environmental and human-associated bacterial communities,
76 novel putative B1 genes were predicted. Twenty-one of these were selected
for experimental validation, whereof 18 expressed the predicted phenotype in E.
coli. Phylogentic analysis revealed that the novel genes formed 59 previously
undescribed gene families. In paper II, a large volume of genomic and metage-
nomic data was searched for novel plasmid-mediated quinolone resistance (qnr)
genes. In total, 611 qnr genes were predicted, of which 20 were putative novel.
Nine of these were experimentally tested in E. coli, whereof eight expressed
the predicted phenotype. In paper III, a new method for identiﬁcation and
reconstruction of novel antibiotic resistance genes from fragmented metagenomic
data was presented. The method is based on gene speciﬁc models, which are
optimized for a high sensitivity and speciﬁcity. The method is furthermore
computationally eﬃcient and can be applied to any class of resistance genes. The
results of this thesis provides a deeper insight to the diversity and evolutionary
history of two types of clinically relevant antibiotic resistance genes. It also
provides new methods for eﬃcient and reliable identiﬁcation of novel resistance
genes in fragmented metagenomic data.
Keywords: antibiotic resistance, metagenomics, big data, carbapenemases,
hidden Markov model.
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1 Background
All today known living organisms depend on their genetic material to function
and grow. The genetic information is encoded in two forms of nucleic acids,
where deoxyribonucleic acid (DNA) acts as repositories and ribonucleic acid
(RNA) act as transmitters. DNA molecules generally contain four types of
nucleotides; adenine (A), thymine (T), guanine (G) and cytosine (C), while
RNA has the same nucleotides with the exception of the replacement of T for
uracil (U). Depending on how these nucleotides are organized, they decide an
organism’s functions and traits. In each cell in every organism, a copy of the
complete set of genetic information is stored and is called the genome. The size
of genomes is highly variable with the smallest viruses having a few thousand
bases to the more than three billion bases of the human genome, and even more
in some species. Most genomes consists of a large number of genes, which are
parts of the genome that contains information about the synthesis of RNA and
molecular proteins Mathews et al. (2000).
In the early 50’s, when it was discovered that proteins were constructed of
amino acids in what seemed to be deﬁned orders (Sanger, 1960), the search
for the blueprint of the protein creation started. Although the existence of
the DNA was proposed shortly thereafter (Watson et al., 1953), it wasn’t until
1965 the ﬁrst nucleic acid molecule in the form of tRNA was sequenced (Holley
et al., 1965). The ﬁrst DNA sequenced was from the bacteriophage λ, which
was completed in 1971 and consisted of 12 bases (Wu and Taylor, 1971), and the
ﬁrst whole genome sequenced was another bacteriophage, φX with 5375 bases,
in 1978. The length of the sequences continued to increase with the ﬁrst human
chromosome sequenced in 1999 (Dunham et al., 1999) and in 2001 the ﬁrst draft
versions of the human genomes 3.2 billion bases were published (Venter et al.,
2001; Lander et al., 2001). The advancements in the sequencing techniques
had until then been achieved mainly with the Sanger method, also referred to
as the "ﬁrst-generation" sequencing, but during the last decade several new
sequencing techniques have emerged. A big breakthrough was the invention of
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the high-throughput second-generation or "next-generation" sequencing (NGS)
techniques. With the second-generation sequencing came the ability to produce
millions of sequence reads in parallel, speeding up the process and reducing
the cost of each read substantially. Although the produced sequence reads
with second-generation are typically not as long and not as accurate as those
produced with Sanger technology, the great throughput of reads makes the
coverage of each DNA fragment high and the ﬁnal sequences more accurate
since each DNA nucleotide is sequences several times on average. Recently,
the next-generation sequencing technologies have been further developed with
the aim to produce even longer reads while maintaining the low price per read
achieved with the second-generation technique (van Dijk et al., 2014). The fast
pace of the development of sequencing techniques have created an enormous
amount of sequence data, and today there are around 86 000 sequenced bacterial
genomes publically available (NCBI, 2017), compared to only 300 sequenced
bacterial genomes 10 years ago (Binnewies et al., 2006).
The massive amount of genomic data has given us unprecedented opportu-
nities to study all life forms on earth. The applications are numerous, ranging
from evolutionary studies to disease preventions. With even better and faster
sequencing techniques, together with new algorithms to handle the data, the
number of applications will most likely be endless.
1.1 Metagenomics
It is estimated that there are over 1030 individual bacterial cells (Whitman et al.,
1998) and between 107 to 109 bacterial species on earth (Curtis et al., 2002;
Dykhuizen, 1998). Historically the study of microorganisms has been focused on
single species, but the vast majority of all microorganisms cannot be cultured
by standard techniques (Hugenholtz et al., 1998). The uncultivable microor-
ganisms represent many diverse organisms living in several unique communities
and they are often distantly related to the cultivable ones (Riesenfeld et al.,
2004b). It was therefore important to develop culture-independent methods
to understand the ecological role of these communities, their genetic diversity
and population structure. To tackle this challenge, a technique which today is
called functional metagenomics was developed (Handelsman et al., 1998). DNA
was taken directly from environmental communities, instead of from a single
organism, and fragmented into pieces. The DNA fragments were then inserted
into cultivable bacteria which were grown under certain conditions such as
under antibiotic exposure, to assess the community for speciﬁc genes. The col-
lective genome of all organisms present in a community was named metagenome.
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However, functional metagenomics has some drawbacks; the procedure is time-
consuming and not every gene can be expressed in a cultivable host. Furthermore,
when searching for a speciﬁc type of gene many fragments must be created
to ensure that the complete gene is captured by the inserted fragments. But
with cheaper and faster sequencing techniques the sequencing of uncultured
microorganisms directly from their community became possible (Heather and
Chain, 2016). The technique, sometimes called shotgun metagenomics, is the
direct isolation and sequencing of genomic DNA from a bacterial community
through high-throughput DNA sequencing (Wooley et al., 2010). Although the
many beneﬁts with metagenomics, it comes with some complications. Compared
to single organism sequencing when the whole genome of a speciﬁc species is
sequenced, the metagenomic data often contain DNA from a large number of
species, and due to the high diversity often present in and in-between microbial
communities, metagenomes are often undersampled. The data is furthermore
often highly fragmented, with fragments sometimes as short as 75 bases, de-
pending on which sequencing technique used. The result is a data set which
is hard to reconstruct through sequence assembly, and often it is not possible
to reconstruct the complete genomes of the organisms present in the sampled
community. The analysis of metagenomic data is therefore challenging, and
demands specially designed methods and algorithms.
During the last years, several big projects have been conducted within the
metagenomic area, including the study of the gut microbiome of 124 European
individuals which resulted in the ﬁrst human gut gene catalog (Qin et al., 2010).
Then came the Human Microbiome Project (Consortium et al., 2012) where
scientists discovered, among other things, that the microbial communities be-
tween body sites of healthy individuals diﬀered remarkably, and the Tara Ocean
project where 7.2 trillion bases of metagenomic data has been sequenced, leading
to new picture of the diversity within the ocean with more than 40 million
non-redundant genes discovered (Armbrust and Palumbi, 2015). The impact of
metagenomics will likely continue to increase, as the amount of metagenomic
data continues to accumulate in publically available databases.
1.2 Antibiotic resistance
Antibiotics are substances that can kill or inhibit the growth of bacteria, and
have since its discovery saved millions of people with life-threatening bacterial
infections and facilitated major improvements in medicine and surgery. The
antibiotic can either be a natural product, produced by speciﬁc microorganisms,
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it can be synthetically constructed, or a combination thereof. During the past
60 years, most antibiotics has been the result of natural production by bacteria
or fungi, with a few exceptions of synthetically constructed antibiotics (Walsh,
2003). There are several classed of antibiotics, but the majority of them were
discovered between 1940 and 1962, and since then only two new classes have
been introduced (Coates et al., 2011).
Antibiotic resistance is the ability of bacteria to withstand the eﬀects of antibi-
otics, and as a result, medicines previously used to treat infections have become
ineﬀective. Bacteria can withstand antibiotics through diﬀerent resistance
mechanisms which can be classiﬁed as intrinsic, acquired or adaptive. Bacteria
with intrinsic resistance often have some inherited characteristics which causes
them to be unaﬀected by antibiotics, and this is a feature of all members of the
species. This characteristic does not change over time, and can for example be
the outer membrane of many Gram-negative bacteria which is impermeable to
certain types of antibiotics (Carlos, 2015). In contrast to the intrinsic resistance,
bacteria can also acquire resistance via mutations and horizontal gene transfer.
Through mobile genetic elements such as plasmids and transposons, these resis-
tance genes can move between bacterial cells and species (Stokes and Gillings,
2011). The acquired resistance can, once obtained, be inherited to daughter
cells of the bacteria. The third variant of resistance is the adaptive resistance,
or stress response, where sudden changes in the environment of a bacterial
community may trigger defense systems which can limit the permeability of the
outer membrane, or by overexpressing eﬄux pumps which leads to a decreased
accumulation of antibiotics, and thus a decreased susceptibility (Carlos, 2015).
The ﬁrst antibiotic in commercial use was the penicillin in the 1940-ies, but
almost immediate after its release, a bacterial produced enzyme with the ability
to hydrolyze it was discovered. (Abraham and Chain, 1940). New types of
antibiotics were developed in response to the increasing resistance, but as soon
as a new drug was on the market, a new type of resistance was discovered.
Today resistance has been recognized to almost every developed antibiotics
(Ventola, 2015) Over time the antibiotic resistant bacteria furthermore have
undergone the development from resistance to single classes of antibiotics to
being multi-drug resistant, often through horizontal gene transfer. In clinical
settings, frequently encountered resistant bacteria are the extended-spectrum
β-lactamase (ESBL) positive Enterobacteriaceae, while other common types
are the Methicillinresistant Staphylococcus aereus (MRSA) and the vancomycin-
resistant enterococci (VRE) (Cantas et al., 2013).
As a last resort treatment for a patient infected with a multi-resistant bacteria
the β-lactam carbapenems are often used. However, recent studies show that
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resistance even to this antibiotic is emerging worldwide. The resistance to
carbapenems is to a large extent due to the expression of carbapenemases, a
class of enzymes where the majority have broad-spectrum substrate proﬁles
(Papp-Wallace et al., 2011). An especially worrisome carbapenemase is the
acquired NDM-1, which was ﬁrst discovered in 2009 (Yong et al., 2009). Only
in a few years, the gene has rapidly spread through pathogens and has now
been found on several geographical locations and isolated in numerous bacterial
species (Walsh et al., 2011).
1.3 Antibiotic resistance and the environment
Antibiotics have been produced naturally by environmental microbial communi-
ties since ancient times, with some estimates pointing back to two billion years
ago (Hall and Barlow, 2004). Consequently, as a result of evolution, antibiotic
resistance have likely been around for a similarly long time (D’Costa et al.,
2011). This would have given the microbes plenty of time to develop a large
and diverse set of resistance genes, with most of them still being undiscovered.
It is clear that the increase of antibiotic usage in human and veterinary settings,
together with the greater movement of people and animals, has led to the
increased prevalence and spread of antibiotic resistance bacteria (Martínez,
2008; Cantas et al., 2013). But human pathogens are, in most cases, not origi-
nally carriers of antibiotic resistance. Instead, the antibiotic resistance genes
encountered in clinical settings are hypothesized to have originated from the
environment (Walsh, 2013). Resistance genes similar and identical to those in
pathogenic bacteria have been discovered in various environmental communi-
ties (Riesenfeld et al., 2004a; Canton, 2009; Boulund et al., 2012), including
pristine environments such as glaciers (Segawa et al., 2013) and 30 000 years
old permafrost samples (D’Costa et al., 2011). Furthermore, environmental and
commensal bacterial communities have been shown to harbor a large diversity
of antibiotic resistance genes, among which many have not been identiﬁed in
clinical settings (Sommer et al., 2009; Forsberg et al., 2012; Wichmann et al.,
2014). It has further been shown that selection pressures, such as antibiotic
exposure, may enrich the abundance and diversity of resistance genetic elements
in these communities (Gillings and Stokes, 2012). It is therefore likely that the
environment has and will continue to act as a reservoir for antibiotic resistance
genes that can be spread to pathogenic bacteria (Allen et al., 2010).
Historically, the studies of antibiotic resistance have been conducted in clinical
settings with pathogenic bacteria in focus. However, to unravel the real diversity
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and abundance of resistance genes it is necessary to turn the investigation to
the environmental and commensal bacterial communities (Bengtsson-Palme
and Larsson, 2015). Because the majority of bacteria inhabiting these com-
munities are uncultivable under standard laboratory conditions, the invention
of metagenomics has provided an unprecedented opportunity to explore these
environments under unbiased conditions. But it is not straightforward to search
for resistance genes in metagenomic data. The data is often large and highly
fragmented with reads from several species, so there is a high probability that
genes existing in low abundance will pass undetected. Secondly, resistance genes
are often located on mobile elements, such as plasmids and transposons, which
can be situated in various contexts, making the assembly of these genes noto-
riously troublesome (Bengtsson-Palme et al., 2014). New methods to analyze
metagenomes are therefore needed in order to identify novel resistance genes
before they spread to pathogens, and to increase the knowledge of the diversity
of speciﬁc classes of antibiotic resistance genes.
2 Results
The aim of this thesis is to identify previously uncharacterized antibiotic re-
sistance genes to further elucidate their abundance, their diversity and their
origin. The ﬁrst two papers, paper I and paper II, were aimed at identifying
novel subclass B1 metallo-β-lactamases and plasmid-mediated qnr genes respec-
tively. Paper III aimed at developing a method to facilitate identiﬁcation of
novel antibiotic resistance genes in fragmented metagenomic data. This chapter
provides an introduction to the three papers together with a summary of the
overall aims and main ﬁndings of each paper.
2.1 Introduction to Paper I
Carbapenems are important broad-spectrum antibiotics often used as a last
resort treatment for patients infected with multi-resistant bacteria. Carbapenem
resistance is caused by carbapenemases, enzymes that often are able to hydrolyze
all known β-lactams in addition to carbapenems. During the last years, the resis-
tance towards carbapenems has increased rapidly in many regions of the world
(Papp-Wallace et al., 2011), and carbapenem resistance genes, that up until a
couple of years ago had never been seen, is now detected in pathogens basically
all over the world. The majority of the mobile carbapenem resistance genes
have been identiﬁed in clinical settings, but it is hypothesized that these genes
originated from environmental bacteria, and from there have made the move into
pathogens. Many acquired and clinically relevant carbapenem resistance genes
such as VIM, IMP and NDM belong to the class metallo-β-lactamases. This
class is further divided based on molecular structure into the three subclasses
B1, B2 and B3. In paper I, the aim was to identify previously uncharacterized
subclass B1 metallo-β-lactamases (B1BL) to obtain a more detailed picture
of the origin and diversity of this important subclass. Using a new developed
computational pipeline we screened more than 5 terabases of metagenomic data
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from human and environmental bacterial communities, as well as all bacterial
genomes and plasmids available in the NCBI GenBank database. In order to
achieve high accuracy, the classiﬁcation in the pipeline was done with a Hidden
Markov model optimized for ﬁnding previously uncharacterized B1BL.
In total, 76 novel B1BL genes were identiﬁed and when clustered together
with all previously reported B1BL genes using a sequence similarity cut-oﬀ of
70%, they formed 59 novel gene families. A phylogenetic tree was created based
on one representative sequence from each of the 59 novel gene families together
with the previously reported B1BL genes. Analysis of the resulting tree showed
that subclass B1 genes can be organized into ﬁve groups, mainly deﬁned by the
taxonomy of the host. We furthermore noticed that all except one previously
identiﬁed mobile B1BL clustered together with chromosomally encoded genes of
the phylum Proteobacteria. Of the identiﬁed novel genes, 21 were selected for
experimental veriﬁcation where the genes where synthetically constructed and
inserted into an Escherichia coli host. A CarbaNP test (Nordmann et al., 2012)
was conducted and showed that 18 of the tested genes had a carbapenemase
activity. The results from this paper signiﬁcally extends the number of identiﬁed
subclass B1 metallo-β-lactamases, and provide a much more detailed picture of
their diversity and evolutionary history.
2.2 Introduction to Paper II
The fully synthetic antibiotic class quinolones were taken into clinical use in
1962, and later in the 1980s an addition of a ﬂuorine on the quinolone yielded
the ﬂuoroquinolones. Since the antibiotic was not derived from natural compo-
nents, it was considered unlikely that ﬂuoroquinolone resistance would emerge.
Nevertheless, in 1998 the ﬁrst plasmid-mediated quinolone resistance (qnr) gene
was discovered. Since then, the qnr genes have rapidly spread and are now
distributed globally in many bacterial genera. As with most other antibiotic
resistance genes, the qnr genes are assumed to have originated from the envi-
ronment. Although several families of qnr genes have been discovered over the
last decade, their true abundance and diversity is still unknown.
The aim of paper II was to screen a high number of genomic and metage-
nomic data in order to discover previously unknown qnr genes and to estimate
their abundance in environmental and commensal bacterial communities. A to-
tal of almost 13 terabases of genomic and metagenomic data was analyzed using
a computational pipeline based on a Hidden Markov model. A total of 362 843
qnr gene fragments were identiﬁed, and 611 qnr genes were predicted. Among
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the 611 identiﬁed qnr genes, 20 was not present or annotated as ﬂuoroquinolone
resistance genes in Genbank, and therefore considered putatively novel qnr
genes. Nine of these were selected for experimental veriﬁcation, whereof eight
showed an increased minimum inhibitory concentration (MIC) to ciproﬂoxacin
when expressed in E. coli. This paper provided the most exhausting search
for qnr genes in both genomic and metagenomic data ever conducted, and
contributed to the extended knowledge about of their relative abundance in
various bacterial communities.
2.3 Introduction to Paper III
The environment is hypothesized to act as reservoir for antibiotic resistance
genes, but the majority of the environmental bacteria are not possible to culti-
vate under standard laboratory conditions. Metagenomics, however, facilitates
the analysis of these bacteria and their corresponding gene pool. However,
metagenomic data is often large and highly fragmented, with many fragments
originating from several diﬀerent species which makes it challenging to work with.
In paper III we present a new method for identifying and reconstructing novel
antibiotic resistance genes from fragmented metagenomic datasets. The method
is an improved version of the methods used in paper I and paper II, and is
constructed to handle large datasets and to create and optimize models for iden-
tiﬁcation of any antibiotic resistance gene. The method does a ﬁrst classiﬁcation
on fragments, with a threshold score optimized for short sequences, to decide
if they originate from the modeled resistance genes. This ﬁrst classiﬁcation
is signiﬁcantly reducing the amount of data and enables the method to be
computationally eﬃcient. The fragments which are classiﬁed as positives are
assembled using a paired-end approach where both reads in the pair are used
even if only one of the reads was positively classiﬁed. In the ﬁnal step of the
method, the assembled contigs are analyzed with the model using a threshold
score optimized for full-length genes. To demonstrate the methods performance,
three models representing three clinically relevant gene classes were created and
used on four metagenomic datasets, which resulted in the identiﬁcation of 72
novel antibiotic resistance genes. The proposed method is the ﬁrst eﬃcient way
of reliable identiﬁcation and reconstruction of novel antibiotic resistance genes
from fragmented metagenomic data.
10 2. Results
3 Future work
Of the 76 novel subclass B1 metallo-β-lactamases discovered in paper I, 21
were phenotypically tested, and the next step will be to extend this number.
The structures of the discovered enzymes will also be, if possible, established
through X-ray crystallization studies. The two identiﬁed B1 genes with previ-
ously unseen changes of the binding sites will be further investigated to study
how the changes aﬀects their substrate spectrum. We furthermore discovered
two putative mobile genes, here a deeper investigation of the genetical context of
the remaining genes would be of interest to investigate their potential mobility.
As the overall concern is the risk that these genes will end up in pathogens
and create a clinical problem, the ﬁtness cost they may carry is another aspect
we are interested in. Low ﬁtness cost, high mobility and a strong resistance
phenotype in Enterobacteriaceae would speak in favor of an increased risk.
The method presented in paper III has several features under implementa-
tion. Since the highest variability in the genes often occurs in the start and
end regions, the highest abundance of retrieved fragments aligns to the center
part of the HMM, often leading to a couple of codons missing in the start
and end positions of the retrieved genes. Here, an elongation step involving
mapping reads to the assembled gene together with an ORF-prediction step
have been proposed and will be implemented. Furthermore, the method will be
made to handle several gene models simultaneously, which will further speed
up the processing time when searching for several classes of resistance genes.
New models representing other gene classes will also be developed using the
creation and optimization framework, and the aim is then to apply the methods
to several new metagenomic datasets. As a next step, the aim is to develop
more reﬁned models, which can make the distinction between phenotypically
diﬀerent, but molecularly very similar genes. This could for example be the
distinction between carbapenem hydrolyzing class A-β-lactamases and other
class A β-lactamases.
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As the amount of public metagenomic data continues to grow, there will be
endless opportunities to compare abundances, investigate trends and explore
the evolutionary origins of antibiotic resistance genes. Furthermore, as the
development of the third generation sequencing techniques moves forward, the
amount of longer sequence reads will increase. It would therefore be of interest
to integrate those longer reads in the gene prediction methods.
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